10:07 AM EST - MediPharm Labs Corp. : Provides an update with respect to the previously announced sale of its facility in Napanee, Ontario to be completed pursuant to the terms of a share purchase agreement entered into with Kensana Health Inc. through a disposition of all of the Company's indirect equity interests in its wholly-owned subsidiary ABcann Medicinals Inc. to Kensana Health for $5.5 million in cash. MediPharm Labs Corp.
shares T.LABS are trading down $0.01 at $0.07.
